About
Fenofibrate is a fibric acid derivative primarily utilized in the treatment of various forms of hyperlipidemia, particularly characterized by elevated triglyceride levels and diminished HDL-C. Its therapeutic action is mediated through the activation of peroxisome proliferator-activated receptor alpha (PPARα), a nuclear receptor that regulates lipid metabolism. Activation of PPARα leads to enhanced lipolysis and the accelerated elimination of triglyceride-rich particles from the plasma, alongside a reduction in hepatic triglyceride synthesis. This mechanism results in a profound decrease in triglyceride levels and a notable increase in beneficial HDL-C, while also exerting a modest lowering effect on LDL-C. Fenofibrate is particularly valuable for patients suffering from severe hypertriglyceridemia, where there is an increased risk of pancreatitis, and for those with mixed dyslipidemia, contributing significantly to the improvement of overall cardiovascular risk profiles and reducing the incidence of related complications.
Uses
- Treatment of severe hypertriglyceridemia.
- Management of primary hypercholesterolemia and mixed dyslipidemia.
- Reduction of cardiovascular risk in certain patient populations.
- Increasing HDL-C levels.
Directions For Use
Take one tablet orally once daily with a meal.
Benefits
- Significantly lowers triglyceride levels.
- Increases beneficial HDL-C.
- Modestly lowers LDL-C.
- Reduces risk of pancreatitis in severe hypertriglyceridemia.
- Improves overall lipid profile.
- Once-daily dosing for convenience.
Side Effects
- Abdominal pain
- Nausea
- Diarrhea
- Headache
- Back pain
- Elevated liver enzymes
- Myalgia (muscle pain)
- Increased creatinine levels
- Gallstones (cholelithiasis)
- Pancreatitis (rare)
- Skin rash
- Photosensitivity
Safety Measures
- Alcohol - Avoid excessive alcohol consumption as it can increase triglyceride levels and the risk of liver damage, which fenofibrate can also affect.
- Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus. Limited human data; animal studies show some adverse effects.
- Breastfeeding - Not recommended during breastfeeding as it is excreted in breast milk and potential effects on the infant are unknown.
- Liver - Contraindicated in active liver disease or unexplained persistent liver function abnormalities. Monitor liver function tests regularly.
- Kidney - Contraindicated in severe renal impairment (eGFR < 30 mL/min/1.73 m²). Dose adjustment is required for moderate renal impairment.
- Lung - No specific contraindications or known adverse effects on lung conditions. Rarely, interstitial lung disease has been reported with fibrates.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!